Theme: Insights of Cardiovascular Imaging

Cardiovascular Imaging 2017

Cardiovascular Imaging 2017

Conference Series LLC invites all the participants from all over the world to attend “Annual Conference on Cardiovascular Imaging” October 31- November 01, 2017 Istanbul, Turkey which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Cardiovascular Imaging 2017 will bring together world-class professors, scientists and cardiologists to discuss strategies for disease remediation for heart, Cardiovascular Imaging Technology and Image Processing, Imaging Cardiovascular Development, Regenerative Medicine and Interventions. Cardiology conferences are designed to provide diverse and current education that will keep medical professionals abreast of the issues affecting the prevention, diagnosis and treatment of cardiovascular disease. The conference will be organized around the theme “Insights of Cardiovascular Imaging”.

Track 1: Cardiovascular Imaging: Clinical Applications

Cardiovascular magnetic resonance (CMR) imaging has evolved rapidly and is now accepted as a powerful diagnostic tool with significant clinical and research applications. Clinical 3 Tesla (3 T) scanners are increasingly available and offer improved diagnostic capabilities compared to 1.5 T scanners for perfusion, viability, and coronary imaging. Although technical challenges remain for cardiac imaging at higher field strengths such as balanced steady state free precession (bSSFP) cine imaging, the majority of cardiac applications are feasible at 3 T with comparable or superior image quality to that of 1.5 T. This review will focus on the benefits and limitations of 3 T CMR for common clinical applications and examine areas in development for potential clinical use.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 2: Cardiac tumors

Cardiac tumors may be primary or secondary, may be related to the heart muscle or pericardium, or may be direct extensions of primary tumors or metastases from adjacent structures.In general, primary cardiac tumors are of  mesothelial or epithelial origin. Tumors include myxomas, fibromas, lipomas, rhabdomyomas, plasma cell granulomas, sarcomas, lymphomas, thymomas, hemangiopericytomas, fibroelastomas, angiomas, hemangiomas, angiomyolipomas/ hamartomas, lymphangiomas, and mycosis fungoides.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 3: Cardiovascular Imaging: Future Prospect

Radiographic, ultrasound, nuclear, and magnetic resonance methods have become indispensable in the management of heart failure (HF). Imaging is widely used in decision making in HF, not only in relation to left ventricular (LV) systolic and diastolic function but also in the selection of medical, device, and surgical therapy in HF and valvular heart disease. Future developments in the care of advanced heart disease, including stem cell therapy, device therapy to control remodeling, and percutaneous valve interventions, as well as the need to identify subclinical heart disease, are likely to expand this use.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 4: Myocardial perfusion imaging

Myocardial perfusion imaging (MPI) is a non-invasive imaging test that shows how well blood flows through (perfuses) your heart muscle. It can show areas of the heart muscle that aren't getting enough blood flow. This test is often called a nuclear stress test. It can also show how well the heart muscle is pumping.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 5: Cardiovascular Imaging Technology and Image Processing

The Cardiovascular Imaging Section utilizes the latest CT, MR, and image processing technology to provide non-invasive imaging of the cardiovascular system.The section continues to practice at the cutting edge by using the latest technology, such as the first dual x-ray source CT scanner, the latest generation of 1.5 and 3TMR systems, and advanced image processing systems including a virtual reality system for medical image evaluation.Heart disease is the leading cause of mortality worldwide. MR imaging is widely used clinically to determine the extent of myocardial infarction or peripheral vascular disease and is playing an increasing role in characterizing atherosclerosis, cardiac hypertrophies, cardiac thrombosis, and congestive heart failure.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 6: Cardiovascular Imaging Development

The cardiovascular system is the first functional organ system to develop within the mammalian embryo. During the early stages of cardiovascular development, the heart and blood vessels undergo rapid growth and remodeling required for embryo viability, proper morphogenesis, and the function of all organ systems. Live imaging of these dynamic events in early mouse embryos is critical to understanding when and how these morphological changes occur during normal development and how mutations and pharmacological agents affect cardiovascular structure and function in vivo. The use of optical coherence tomography (OCT) allows for rapid, three-dimensional structural and functional imaging of mouse embryos at cellular resolution without the aid of contrast agents. In this chapter, we will describe how OCT can be used to assess the morphology of vessels and the heart, dynamic analysis of cardiac function, and hemodynamics within extraembryonic and embryonic blood vessels.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 7: Regenerative Medicine and Interventions

Regenerative medicine (RM) technologies, such as cell therapy, gene transfer and tissue engineering, are expected to move the field of orthopedics into a new era. Now that more and more attempts are underway to translate preclinical research into clinical studies, it is time to proactively discuss the ethical issues associated with first-in-human applications of RM interventions for musculoskeletal disorders. The design and launch of early clinical trials will be ethically challenging due to the specific features of RM in general, and the application for musculoskeletal disorders specifically. In this paper, we identify three sets of ethical issues that need to be addressed when considering initiating early clinical trials: assessment of risks and benefits; designing a study in terms of outcome measures and comparators; and participant selection. These issues are particularly emphasized in RM research that aims to apply these approaches in an early stage of degenerative musculoskeletal disorders.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 8: Imaging in Cardiovascular Pathology

Cardiovascular MR imaging (CMR) was performed in 32 patients who were diagnosed with myocarditis by clinical criteria. To determine whether CMR visualizes areas of active myocarditis, endomyocardial biopsy was taken from the region of contrast enhancement and submitted to histopathologic analysis. Follow-up was performed 3 month later. Contrast enhancement was present in 28 patients (88%) and was usually seen with one or several foci in the myocardium. Foci were most frequently located in the lateral free wall.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 9: Probes for Cardiovascular Imaging

Molecular magnetic resonance (MR) imaging plays an important role in studying molecular and cellular processes associated with heart disease. Targeted probes that recognize important biomarkers of atherosclerosis, apoptosis, necrosis, angiogenesis, thrombosis and inflammation have been developed.Heart disease is the leading cause of mortality worldwide. MR imaging is widely used clinically to determine the extent of myocardial infarction or peripheral vascular disease and is playing an increasing role in characterizing atherosclerosis, cardiac hypertrophies, cardiac thrombosis, and congestive heart failure.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 10: Myocardial Mapping

Myocardial fibrosis is a common endpoint in a variety of cardiac diseases and a major independent predictor of adverse cardiac outcomes. Short of histopathologic analysis, which is limited by sampling bias, most diagnostic modalities are limited in their depiction of myocardial fibrosis. Cardiac magnetic resonance (MR) imaging has the advantage of providing detailed soft-tissue characterization, and a variety of novel quantification methods have further improved its usefulness. Contrast material-enhanced cardiac MR imaging depends on differences in signal intensity between regions of scarring and adjacent normal myocardium. Diffuse myocardial fibrosis lacks these differences in signal intensity. Measurement of myocardial T1 times (T1 mapping) with gadolinium-enhanced inversion recovery-prepared sequences may depict diffuse myocardial fibrosis and has good correlation with ex vivo fibrosis content. T1 mapping calculates myocardial T1 relaxation times with image-based signal intensities and may be performed with standard cardiac MR imagers and radiologic workstations. Myocardium with diffuse fibrosis has greater retention of contrast material, resulting in T1 times that are shorter than those in normal myocardium.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 11: Diagnostic approach to Myocardial Mechanics

The effects on myocardial mechanics of acute, artificial aortic and mitral regurgitation were studied in the dog to determine the manner in which the changes in load induced by valvular regurgitation alter ventricular performance. With mitral and aortic regurgitant volumes of approximately the same magnitude as the forward stroke volume, immediate increases occurred in total stroke volume, left ventricular enddiastolic pressure, and peak ejection velocity, whereas contractility remained unchanged. Although calculated myocardial fiber tension rose, the rate of decline of tension during ejection was accelerated with regurgitation due to the more rapid decrease in ventricular size. Average tension therefore decreased relative to average pressure.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 12: Clinical Trials in Cardiology

Several features of cardiovascular devices raise considerations for clinical trial conduct. Prospective, randomized, controlled trials remain the highest quality evidence for safety and effectiveness assessments, but, for instance, blinding may be challenging. In order to avoid bias and not confound data interpretation, the use of objective endpoints and blinding patients, study staff, core labs, and clinical endpoint committees to treatment assignment are helpful approaches. Anticipation of potential bias should be considered and planned for prospectively in a cardiovascular device trial.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

 

Track 13: Pediatric cardiologist

 

A pediatric cardiologist is a pediatrician who has received extensive training in diagnosing and treating children's cardiac problems. Evaluation and treatment may begin with the fetus since heart problems can now be detected before birth.When a pediatrician suspects a heart problem, he or she may ask a pediatric cardiologist to investigate further.Common causes for a referral to the pediatric cardiologist include heart murmurs, chest pain, dizzy spell(s) or palpitations. Initial evaluations may result in the patient and his/her parents being reassured that there is nothing to worry about.A pediatric cardiologist is trained to perform and interpret procedures such as electrocardiograms, echocardiograms and exercise tests. In cases of more significant heart disease, a pediatric cardiologist may perform a cardiac catheterization in order to diagnose or treat the child's heart problem. If the child needs to be hospitalized, the pediatric cardiologist and pediatric cardiac surgeon work together in planning cardiac surgery, when needed. However, in all cases the pediatric cardiologist is there, every step of the way.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 14: Advances in cardiology education

There have been some tremendous recent advances across the spectrum of imaging modalities in cardiology, and to do justice to all of them in a limited review article is difficult. Advances in Cardiovascular Imaging reviews clinically relevant information regarding heart failure and arrhythmias as well as ischemic, structural and valvular heart disease.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 15: Cardiologist Training and education

The future of cardiology rests in the hands and minds of cardiovascular trainees and fellowship programs. Education and training is rapidly changing, and the paradigm of "see one, do one, teach one" has now been replaced by formal assessments of competency, the incorporation of practice improvement and systems-based practice, and a focus on duty hours. To keep up with the expanding knowledge and science in cardiovascular medicine, the cardiology community needs to understand new educational initiatives and formulate pathways to teach, mentor, and educate trainees to become competent cardiovascular specialists.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 16: Case reports in Cardiovascular Imaging

Cardiology is a branch of medicine dealing with disorders of the heart. Heart is an important muscular organ in humans and other animals, pumps blood through the blood vessels of the circulatory system. The drugs that are used to treat other disorders in body, show a great impact on heart causing various side effects. Hence case reports on cardiac arrest and diseases have a great value and help in advancing and development of treatment strategies.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Track 17: Arrhythmia

Imaging of the heart is crucial in the invasive treatment of cardiac rhythm disorders. Fluoroscopy is the standard imaging modality to guide catheter positioning in most simple arrhythmias such as supraventricular tachycardias and typical atrial flutter.Imaging of the heart has played an important role in defining cardiac structures and characterising the arrhythmic substrates. Among the available imaging modalities, magnetic resonance imaging (MRI) has led to a better understanding of the mechanisms of cardiac arrhythmias and hence to improved ablation results.

Related conferences: 8th Gobal Cardiologists Annual Meeting July 18-20, 2016 Berlin, Germany; 7th World Cardiothoracic Meeting March 29-30, 2016 Atlanta, USA; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; International conference on Cardio Vascular Medicine October 10-11, 2016 Manchester, UK; International Conference on Angiology December 08-10, 2016 San Antonio, USA; World Cardiology Conference October 10-12, 2016 Manchester, UK; Echo Cardiography Conference June 06-07, 2016 London, UK; 8th Annual The Heart Beat of Cardiology December 10-12, 2015, Chicago, USA;  World Congress of Cardiology & Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; PreHT 2016 - The 4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome, Venice, Italy; WCC 2016 - World Congress of Cardiology & Cardiovascular Health, Mexico City, Mexico

Conference Series LLC invites you to attend the Annual Conference on Cardiovascular Imaging to be held at  Istanbul, Turkey during October 31- November 01 2017 which will bring together world-class professors, scientists and cardiologists to discuss strategies for cardiovascular Imaging.

The division of Cardiovascular Imaging interprets cross sectional imaging studies of the heart and vascular system using Computed Tomography (CT or "CAT" scans) and Magnetic Resonance Imaging (MRI) with a volume of more than 2,500 studies each year. Both CT and MRI are non-invasive imaging modalities, meaning that no catheterization is required. MUSC operates the most up-to-date, cutting edge imaging equipment to ensure optimal diagnostic quality in patient care while also minimizing patient exposure to ionizing radiation. In addition, MUSC has long-standing experience in performing and interpreting cardiovascular imaging studies with unparalleled expertise in the Lowcountry and beyond.

In most instances, imaging studies are performed with contrast enhancement (iodine-based for CT, gadolinium-based for MRI), which is injected through a small intravenous access in an arm vein. CT scans are used primarily to evaluate vascular structures, such as the coronary arteries or the aorta and its branch vessels. The primary strength of MRI is tissue characterization and its ability to evaluate the heart muscle for function, perfusion and viability.  MRI is also helpful in valvular and congenital heart disease.

Cardiovascular Imaging is a common test. It's used to diagnose and assess many diseases and conditions, including:

1. Coronary heart disease

2. Damage caused by a heart attack

3. Heart failure

4. Heart valve problems

5. Congenital heart defects (heart defects present at birth)

6. Pericarditis (a condition in which the membrane, or sac, around your heart is inflamed)

7. Cardiac tumors

International cardiovascular Imaging conference series is designed to provide diverse and current education that will keep medical professionals abreast of the issues affecting the prevention, diagnosis and treatment of Cardiac disorders. In recent years, cardiac and vascular imaging devices have been developed which helped for replacement and repair therapy for the treatment of cardiac disorders. Robotic Imaging are introduced for the cardiac and vascular surgery which has been was beneficial in the wide range.

Conference Series Organizes 1000+ Global events every year across the globe with support from 1000+ more scientific societies and Publishes 500 Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Cardiology-2015

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects of clinical skills, OMICS 5th International Conference on Clinical & Experimental Cardiology was held during April 27-29, 2015 in Philadelphia, USA

OMICS Group played host to a diverse panel of key members of the Cardiology community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology specialties. This event was really aimed for examining where the real cardiological specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Heart Diseases, Congenital Heart Diseases, Cardiac Therapeutic Agents, Biophysics and Systems Biology, Interventional Cardiology, Cancer and Heart, Current Research in Cardiology and Cardiac Surgery as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Cardiology-2015 Organizing Committee would like to thank the Moderators of the conference, Dr. Anastasia Susie Mihailidou, Royal North Shore Hospital & Kolling Institute, Australia and Dr. Mahazarin Ginwalla, University Hospitals Case Medical Center, USA who contributed a lot for the smooth functioning of this event.

We are also thank full to all the speakers who made this event a grand success, our special thanks to Stacy Masucci, Elsevier and Dr. John E. Strobeck, Daxor Corporation  for exhibiting at the conference, many thanks to all the media partners for the promotion of our event.

The highlights of the meeting were the eponymous lectures, delivered by Louis Samuels from Thomas Jefferson University School of Medicine, The Lankenau Heart Institute, USA, Anthony Martin Gerdes from New York Institute of Technology-College of Osteopathic Medicine, USA, Kate M Denton from Monash University, Australia, Yoshiaki Omura from New York Medical College, Heart Disease Research Foundation, USA, Robert M Mentzer from Wayne State University School of Medicine, USA, Karlheinz Seidl from Klinikum Ingolstadt GmbH, Germany. These talks were of great interest to the general cardiologists and were enormously informative.


Past Reports  Proceedings  Gallery  

Cardiology-2014

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects of clinical skills, OMICS 4th International Conference on Clinical & Experimental Cardiology was held during April 14-16, 2014 in San Antonio, USA

OMICS Group played host to a diverse panel of key members of the Cardiology community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology specialties. This event was really aimed for examining where the real cardio logical specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Heart Diseases, Congenital Heart Diseases, Cardiac Therapeutic Agents, Biophysics and Systems Biology, Interventional Cardiology, Cancer and Heart, Current Research in Cardiology, and Cardiac Surgery as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Cardiology-2014 Organizing Committee would like to thank the Moderator of the conference, Dr. Anastasia Susie Mihailidou, Royal North Shore Hospital, Australia who contributed a lot for the smooth functioning of this event.

The highlights of the meeting were the eponymous lectures, delivered by Louis Samuels, Thomas Jefferson University School of Medicine, USA, Richard J. Frink, Heart Research Foundation of Sacramento, USA, Bradley Field Bale, Bale/Doneen Method, USA, Karlheinz Seidl, Klinikum Ingolstadt, Germany. These talks were of great interest to the general cardiologists and were enormously informative.


Past Reports  Gallery  

Cardiology-2013

3rd International Conference on Clinical & Experimental Cardiology (Cardiology -2013) held during April 15-17, 2013 at Chicago/Northbrook, USA, was a dynamic forum for all cardiologists, healthcare professionals, scientists and medical executives from around the world who are actively involved in patient care, research, therapeutics development including basic, translational, and clinical aspects, epidemiology, prevention, diagnosis, and drug discovery and development. The conference provided participants a platform to exchange ideas, and to share breakthroughs and promising solutions to the most important issues in the field.

The day featured formal presentations from key researchers as well as time for questions and informal discussion. The theme of the conference was “Emerging interventions in clinical cardiology and cardiac surgery”.

Keynote sessions were delivered by great speakers, Louis E Samuels, Lankenau Medical Center, USA, Vincent DOR, Centre Cardiothoracique de Monaco, Monaco Cedex, Richard J Frink, Heart Research Foundation of Sacramento, USA, Ming K Heng, University of California, USA. They made excellent presentations and their experiences gained inside/outside the lab were warmly discussed with the audiences at the keynote forum.

The conference was chaired by Xiaoping Ren, James D Fett, Ming k heng, Emad Aziz, Samuel C. Dudley, Anthony Ashton, Alexander D. Verin, Anastasia Susie Mihailidou, JanGlatz, Mentzer, Dr. Ramin Artang, Louis Samuels, and Geetha Bhat.

During the conference, a workshop was introduced by Jozsef Pal Vas and Noemi Csaszar, Hungarian Association of Hypnosis, Hungary. The title for the workshop was “Tandem hypnotherapy (THT) as a new method functioned at sensori-motor level”.

Along with the participants of Cardiology Conference, we would like to express our gratitude to Mr. Frank King, The Cardiac Comedian, for his special appearance at the conference.

 


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 31- November 01, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Media Partners

Conferenceseries Destinations